NIH PAS · NIDDK · R01
PAS-25-205: Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and the National Heart, Lung, and Blood Institute (NHLBI). Investigator-initiated research project grant applications (R01s) in specific areas of basic and early translational hematology research are invited to this program that supports growth in the nonmalignant hematology research domain. Specific emerging topics that are at the leading edge of the field will change over time and will be updated…
- NOFO number
- PAS-25-205
- Type
- PAS
- Activity code
- R01
- Primary institute
- NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
- Clinical trials
- Not Allowed
- Posted
- Nov 6, 2024
- Opens
- Jan 5, 2025
- Expires
- Jan 7, 2028
PAS-25-205 due dates
3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 05, 2025 | March 05, 2025 * | Not Applicable | July 2025 | October 2025 | December 2025 |
| June 05, 2025 | July 05, 2025 * | Not Applicable | November 2025 | January 2026 | April 2026 |
| October 05, 2025 | November 05, 2025 * | Not Applicable | March 2026 | May 2026 | July 2026 |
| February 05, 2026 | March 05, 2026 * | Not Applicable | July 2026 | October 2026 | December 2026 |
| June 05, 2026 | July 05, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 05, 2026 | November 05, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 05, 2027 | March 05, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 05, 2027 | July 05, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 05, 2027 | November 05, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAS-25-205
NIH RePORTER lists 27 projects funded under PAS-25-205 in FY2022–FY2026, with $18.3M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
27
Distinct projects, FY2022–FY2026
New awards
19
Type 1 (new project) award records
NIH funding
$18.3M
Award dollars under PAS-25-205, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 27 | 19 | $18.3M |
Institutions with the most funding
- University of Wisconsin-Madison$3.0M · 5 projects
- University of Tx MD Anderson Can Ctr$1.6M · 1 project
- Children's Hosp of Philadelphia$1.6M · 2 projects
- St. Jude Children's Research Hospital$1.4M · 2 projects
- Cincinnati Childrens Hosp Med Ctr$1.4M · 2 projects
- Pennsylvania State University, the$1.1M · 2 projects
- Sloan-Kettering Inst Can Research$903K · 1 project
- Dana-Farber Cancer Inst$867K · 1 project
Funding institutes
- NIDDK$10.2M · 16
- NHLBI$6.8M · 9
- NIA$1.2M · 2
Activity codes funded
- R0124 records
- R563 records
Most recent new awards
- Role of arginine metabolism in stress erythropoiesis (opens NIH RePORTER)
Pennsylvania State University, the · 1R01HL184576-01 · NHLBI · Notice Aug 24, 2026
$485KR01
- Microbial contributors to steady state hematopoiesis (opens NIH RePORTER)
Washington University · 1R01DK145882-01A1 · NIDDK · Notice Aug 19, 2026
$822KR01
- Translesion Synthesis DNA Polymerases in Mitigating Replication Stress (opens NIH RePORTER)
Children's Hosp of Philadelphia · 1R01HL188167-01 · NHLBI · Notice Aug 17, 2026
$851KR01
- Chromatin remodelers in erythropoiesis and hemoglobin regulation (opens NIH RePORTER)
Children's Hosp of Philadelphia · 1R01DK144080-01A1 · NIDDK · Notice Aug 14, 2026
$700KR01
- Molecular mechanisms that control hematopoietic stem cell lineage bias (opens NIH RePORTER)
University of Wisconsin-Madison · 1R01HL176783-01A1 · NHLBI · Notice Aug 14, 2026
$605KR01
- Regulation of long-lasting hematopoietic multipotent progenitors (opens NIH RePORTER)
Cincinnati Childrens Hosp Med Ctr · 1R01HL187582-01 · NHLBI · Notice Aug 12, 2026
$716KR01
What its predecessor PAS-22-096 funded
PAS-25-205 reissues PAS-22-096. Its funding history is the best guide to who wins under this program: 66 projects and $84.9M in FY2022–FY2026.
Projects funded
66
Distinct projects, FY2022–FY2026
New awards
52
Type 1 (new project) award records
NIH funding
$84.9M
Award dollars under PAS-22-096, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 2 | 2 | $453K |
| FY2023 | 29 | 20 | $11.2M |
| FY2024 | 40 | 16 | $19.2M |
| FY2025 | 57 | 14 | $27.8M |
| FY2026 | 45 | 0 | $26.3M |
Institutions with the most funding
- Cincinnati Childrens Hosp Med Ctr$6.6M · 4 projects
- Boston Children's Hospital$5.5M · 4 projects
- University of Wisconsin-Madison$4.8M · 4 projects
- Albert Einstein College of Medicine$4.7M · 3 projects
- Icahn School of Medicine at Mount Sinai$4.4M · 2 projects
- University of Pittsburgh at Pittsburgh$4.1M · 2 projects
- Yale University$4.0M · 3 projects
- St. Jude Children's Research Hospital$3.5M · 2 projects
Funding institutes
- NIDDK$43.3M · 100
- NHLBI$35.8M · 62
- NIA$5.8M · 11
Activity codes funded
- R01158 records
- R5615 records
Most recent new awards
- Dissecting the Roles of PPM1D and TP53 in Hematopoietic Stem Cells and Clonal Hematopoiesis (opens NIH RePORTER)
Massachusetts General Hospital · 1R56DK142828-01 · NIDDK · Notice Sep 16, 2025
$133KR56
- Protein Aggregation in Hematopoietic Stem Cells (opens NIH RePORTER)
University of California, San Diego · 1R01HL180754-01 · NHLBI · Notice Sep 12, 2025
$536KR01
- Early myeloid lineage specification mechanisms at the top of the hematopoietic hierarchy (opens NIH RePORTER)
Washington University · 1R56DK139218-01A1 · NIDDK · Notice Sep 11, 2025
$87KR56
- Inflammatory landscapes shaped by bone marrow cavities define hematopoietic response to stress and clonal selection (opens NIH RePORTER)
University of Rochester · 1R56DK143951-01 · NIDDK · Notice Sep 11, 2025
$133KR56
- Stress Granules in Red Blood Cell Development (opens NIH RePORTER)
Boston Children's Hospital · 1R01DK143991-01 · NIDDK · Notice Sep 10, 2025
$801KR01
- CLINICAL SIGNIFICANCE OF SOMATIC MOSAIC STATES IN THE CONTEXT OF SHORT TELOMERES (opens NIH RePORTER)
Mayo Clinic Rochester · 1R56DK141633-01 · NIDDK · Notice Sep 9, 2025
$150KR56
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
3 NIH institutes and offices take applications under PAS-25-205. Contact the program officer at the institute that fits your research before applying.
- NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
- NHLBI · National Heart, Lung, and Blood Institute
- NIA · National Institute on Aging
Related notices
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewRenewalResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are not limited but need to reflect the actual needs of the proposed project.
- Project period
- The scope of the proposed project should determine the project period.  The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- NIH intends to fund an estimated 5–8 awards beyond its regular/standard R01 funding policies, corresponding to a total of 2,500,000 in FY 2025. Future year amounts will depend on annual appropriations.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAS-22-096.
Other open NOFOs for R01
- PAS-25-073Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)NIDDK · next due Feb 5, 2027
- PAR-25-379Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)NIDA · next due Oct 21, 2026
- PAR-25-322Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)OD · next due Jan 26, 2027
- PA-25-301NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)NIH · next due Feb 5, 2027
- PA-25-305NIH Research Project Grant (Parent R01 Clinical Trial Required)NIH · next due Feb 5, 2027
- PAR-25-144Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.